These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 21807980)

  • 1. OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae.
    García-Sureda L; Doménech-Sánchez A; Barbier M; Juan C; Gascó J; Albertí S
    Antimicrob Agents Chemother; 2011 Oct; 55(10):4742-7. PubMed ID: 21807980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global Trends in Proteome Remodeling of the Outer Membrane Modulate Antimicrobial Permeability in Klebsiella pneumoniae.
    Rocker A; Lacey JA; Belousoff MJ; Wilksch JJ; Strugnell RA; Davies MR; Lithgow T
    mBio; 2020 Apr; 11(2):. PubMed ID: 32291303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of association of OmpK35 and OmpK36 alteration and bla
    Hamzaoui Z; Ocampo-Sosa A; Fernandez Martinez M; Landolsi S; Ferjani S; Maamar E; Saidani M; Slim A; Martinez-Martinez L; Boutiba-Ben Boubaker I
    Int J Antimicrob Agents; 2018 Dec; 52(6):898-905. PubMed ID: 29621592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Klebsiella pneumoniae LamB Porin in antimicrobial resistance.
    García-Sureda L; Juan C; Doménech-Sánchez A; Albertí S
    Antimicrob Agents Chemother; 2011 Apr; 55(4):1803-5. PubMed ID: 21282437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla(ACT-1) beta-lactamase production, porin OmpK35/36 insertional inactivation, and down-regulation of the phosphate transport porin phoe.
    Kaczmarek FM; Dib-Hajj F; Shang W; Gootz TD
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3396-406. PubMed ID: 17005822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
    Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global survey of Klebsiella pneumoniae major porins from ertapenem non-susceptible isolates lacking carbapenemases.
    Wise MG; Horvath E; Young K; Sahm DF; Kazmierczak KM
    J Med Microbiol; 2018 Mar; 67(3):289-295. PubMed ID: 29458684
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced Susceptibility to Carbapenems in a Klebsiella pneumoniae Clinical Isolate Producing SCO-1 and CTX-M-15 β-Lactamases Together with OmpK35 and OmpK36 Porin Deficiency.
    Venditti C; Butera O; Proia A; Rigacci L; Mariani B; Parisi G; Messina F; Capone A; Nisii C; Di Caro A
    Antimicrob Agents Chemother; 2020 Jul; 64(8):. PubMed ID: 32423955
    [No Abstract]   [Full Text] [Related]  

  • 11. Acquisition of carbapenem resistance in multiresistant Klebsiella pneumoniae strains harbouring blaCTX-M-15, qnrS1 and aac(6')-Ib-cr genes.
    Ruiz E; Ocampo-Sosa AA; Rezusta A; Revillo MJ; Román E; Torres C; Martínez-Martínez L
    J Med Microbiol; 2012 May; 61(Pt 5):672-677. PubMed ID: 22282462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the Genetic Background of KPC-2-Producing
    Wu LT; Guo MK; Ke SC; Lin YP; Pang YC; Nguyen HV; Chen CM
    Microb Drug Resist; 2020 Sep; 26(9):1050-1057. PubMed ID: 32283046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae.
    Landman D; Bratu S; Quale J
    J Med Microbiol; 2009 Oct; 58(Pt 10):1303-1308. PubMed ID: 19556371
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contribution of β-lactamases and porin proteins OmpK35 and OmpK36 to carbapenem resistance in clinical isolates of KPC-2-producing Klebsiella pneumoniae.
    Zhang Y; Jiang X; Wang Y; Li G; Tian Y; Liu H; Ai F; Ma Y; Wang B; Ruan F; Rajakumar K
    Antimicrob Agents Chemother; 2014; 58(2):1214-7. PubMed ID: 24277031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Outbreak of NDM-1-Producing Klebsiella pneumoniae, Associated with OmpK35 and OmpK36 Porin Loss in Tunisia.
    Hamzaoui Z; Ocampo-Sosa A; Maamar E; Fernandez Martinez M; Ferjani S; Hammami S; Harbaoui S; Genel N; Arlet G; Saidani M; Slim A; Boutiba-Ben Boubaker I; Martinez-Martinez L
    Microb Drug Resist; 2018 Oct; 24(8):1137-1147. PubMed ID: 29373087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proof of the triple prerequisite conditions which are essential for carbapenem resistance development in Klebsiella pneumoniae by using radiation-mediated mutagenesis.
    Pinto NA; D'Souza R; Nguyen LP; Vu TN; Yong D
    FEMS Microbiol Lett; 2021 Jan; 368(1):. PubMed ID: 33469646
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteomics profiling of ertapenem challenged major porin deficient carbapenem-resistant Klebsiella pneumoniae.
    Yuan PB; Ling JH; Zhu JH; Peng C; Chen EZ; Zhong YX; Liu WT; Wang LJ; Yang L; Chen DQ
    J Proteomics; 2022 Sep; 268():104715. PubMed ID: 36058541
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of β-lactam plus β-lactam-enhancer combination cefepime/zidebactam against Klebsiella pneumoniae harbouring defective OmpK35/36 porins and carbapenemases.
    Joshi P; Shrivastava R; Bhagwat S; Patel M
    Diagn Microbiol Infect Dis; 2021 Oct; 101(2):115481. PubMed ID: 34332307
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant
    Lee YQ; Sri La Sri Ponnampalavanar S; Wong JH; Kong ZX; Ngoi ST; Karunakaran R; Lau MY; Abdul Jabar K; Teh CSJ
    Front Cell Infect Microbiol; 2024; 14():1464816. PubMed ID: 39359938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.